Phlox Therapeutics

Phlox Therapeutics is a biotech company in Naarden, Netherlands, founded in 2022. It has 2 recorded funding rounds, most recently a Venture Round in November 2024.

Curing genetic heart diseases

Employees
1–10
Founded
2022
Business Model
B2B
Last Round
Venture RoundNov 2024
Rounds
2

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

RNA-based biotech therapeutic company

Summary

It lists 1–10 employees. Its most recent funding was a Venture Round in Nov 2024.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundNov 2024

Sign up to see all 2 events

Funding: Extension Round through Venture Round. Amounts, valuations, and investors where available.

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Phlox Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/phlox-therapeutics"><img src="https://indexed.vc/api/badge/company/phlox-therapeutics" alt="Phlox Therapeutics on Indexed.vc" width="260" height="76" /></a>